Search research articles
Contact Us
Filters
Showing results (181-190 of 436) with videos related to
Page
of 44
Sort By:
Journal of the American Society of Nephrology : JASN
|
January 23, 2003
A propensity analysis of late versus early nephrologist referral and mortality on dialysis
Wolfgang C Winkelmayer, William F Owen, Raisa Levin, et al.
The Milbank Quarterly
|
August 10, 2021
Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards
Liam Bendicksen, Benjamin N Rome, Jerry Avorn, et al.
Circulation
|
November 26, 2009
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome
Jeremy A Rassen, Niteesh K Choudhry, Jerry Avorn, et al.
The New England Journal of Medicine
|
January 15, 2015
Practical, legal, and ethical issues in expanded access to investigational drugs
Jonathan J Darrow, Ameet Sarpatwari, Jerry Avorn, et al.
Plos Medicine
|
August 18, 2012
Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures
Aaron S Kesselheim, Bo Wang, David M Studdert, et al.
Journal of the American College of Cardiology
|
February 12, 2011
The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels
Niteesh K Choudhry, Amanda R Patrick, Robert J Glynn, et al.
BMJ Quality & Safety
|
April 27, 2013
Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs
Aaron S Kesselheim, Jessica M Franklin, Jerry Avorn, et al.
Annals of Internal Medicine
|
April 17, 2002
Correction: cost-effectiveness of statins in older patients with myocardial infarction
David A Ganz, Karen M Kuntz, Joshua S Benner, et al.
The American Journal of Medicine
|
December 28, 2005
Lipid levels and bone mineral density
Daniel H Solomon, Jerry Avorn, Claire F Canning, et al.
JAMA
|
August 25, 2018
Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents
Chana A Sacks, ChangWon C Lee, Aaron S Kesselheim, et al.
Page
of 44
Search research articles
Search
Showing results (181-190 of 436) with videos related to
Sort By:
Page
of 44
Journal of the American Society of Nephrology : JASN
|
January 23, 2003
A propensity analysis of late versus early nephrologist referral and mortality on dialysis
Wolfgang C Winkelmayer, William F Owen, Raisa Levin, et al.
The Milbank Quarterly
|
August 10, 2021
Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards
Liam Bendicksen, Benjamin N Rome, Jerry Avorn, et al.
Circulation
|
November 26, 2009
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome
Jeremy A Rassen, Niteesh K Choudhry, Jerry Avorn, et al.
The New England Journal of Medicine
|
January 15, 2015
Practical, legal, and ethical issues in expanded access to investigational drugs
Jonathan J Darrow, Ameet Sarpatwari, Jerry Avorn, et al.
Plos Medicine
|
August 18, 2012
Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures
Aaron S Kesselheim, Bo Wang, David M Studdert, et al.
Journal of the American College of Cardiology
|
February 12, 2011
The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels
Niteesh K Choudhry, Amanda R Patrick, Robert J Glynn, et al.
BMJ Quality & Safety
|
April 27, 2013
Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs
Aaron S Kesselheim, Jessica M Franklin, Jerry Avorn, et al.
Annals of Internal Medicine
|
April 17, 2002
Correction: cost-effectiveness of statins in older patients with myocardial infarction
David A Ganz, Karen M Kuntz, Joshua S Benner, et al.
The American Journal of Medicine
|
December 28, 2005
Lipid levels and bone mineral density
Daniel H Solomon, Jerry Avorn, Claire F Canning, et al.
JAMA
|
August 25, 2018
Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents
Chana A Sacks, ChangWon C Lee, Aaron S Kesselheim, et al.
Page
of 44